ArticleMetabolism open2026
Association between stress hyperglycemia ratio and 72-hour delirium in critically ill patients: A retrospective cohort study from the MIMIC-IV database.
Article in Metabolism open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stress hyperglycemia, quantified by the stress hyperglycemia ratio (SHR), reflects the acute glycemic response relative to chronic glycemic status. Its association with intensive care unit (ICU)-acquired delirium and the mechanistic pathway linking SHR to mortality remain poorly characterized. Methods: In this retrospective cohort study of 7397 critically ill adults from the MIMIC-IV database, we examined the association between SHR and 72-h delirium using multivariable Cox proportional-hazards regression. Restricted cubic spline analysis was used to characterize the dose-response relationship. Mediation analyses were employed to evaluate whether delirium mediates the effect of SHR on 28-day and 365-day all-cause mortality, with E-value analysis to assess robustness to unmeasured confounding. Results: Overall, 1259 patients developed delirium within 72 h of ICU admission, with a median onset of 11.25 h. Patients in the highest SHR quartile had a significantly higher hazard of delirium than those in the lowest quartile (HR 1.23, 95% CI 1.04-1.45; Conclusions: Elevated SHR is independently associated with an increased risk of ICU-acquired delirium in a linear, dose-dependent manner, and delirium fully mediates the indirect effect of SHR on short- and long-term mortality. These findings support SHR as a readily obtainable biomarker for early delirium risk stratification among critically ill patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.